medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's Disease. Inflamm Bowel Dis Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N. PMID: 40522972 [PubMed - as supplied by publisher]
	Predicting mucosal healing in Crohn's disease: development of a deep-learning model based on intestinal ultrasound images. Insights Imaging Ma L, Chen Y, Fu X, Qin J, Luo Y, Gao Y, Li W, Xiao M, Cao Z, Shi J, Zhu Q, Guo C, Wu J. PMID: 40522531 [PubMed]
	Epigenetics and Expression of the Wnt Signaling Pathway in Ulcerative Colitis. Turk J Gastroenterol Altintas Z, Erdal ME, Altintas E. PMID: 40521787 [PubMed - as supplied by publisher]
	Alterations of gut microbiota and metabolites in children with Crohn's disease and their correlation with disease activity. Transl Pediatr Kong Y, Zhang T, Ye X, Wu J. PMID: 40519722 [PubMed]
	Systematic review: the use of tacrolimus in steroid-refractory ulcerative colitis. Ther Adv Chronic Dis Jangra V, Yilmaz D, Soares D, Taylor F, Andreani S, Hotouras A. PMID: 40519524 [PubMed]
	New insight for ulcerative colitis diagnosis via serum netrin-1 and galectin-1 biomarkers. Hum Antibodies Alahmed A, Al-Rubaee E. PMID: 40518925 [PubMed - as supplied by publisher]
	A Novel Switching of Artificial Intelligence to Generate Simultaneously Multimodal Images to Assess Inflammation and Predict Outcomes in Ulcerative Colitis-(With Video). Dig Endosc Iacucci M, Zammarchi I, Santacroce G, Kolawole BB, Chaudhari U, Del Amor R, Meseguer P, Naranjo V, Puga-Tejada M, Capobianco I, Ditonno I, Buda A, Hayes B, Crotty R, Bisschops R, Ghosh S, Grisan E, PICaSSO group. PMID: 40518924 [PubMed - as supplied by publisher]
	Outcomes of Fecal Diversion in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis. J Dig Dis Hartley I, Sarraf B, Wilding H, Segal JP, Ding NS. PMID: 40518593 [PubMed - as supplied by publisher]
	Intestinal Ultrasound and Its Advanced Modalities in Characterizing Strictures in Crohn's Disease. Clin Gastroenterol Hepatol de Voogd F, Beek KJ, Pruijt M, van Rijn K, van der Bilt J, Buskens C, Bemelman W, Neefjes-Borst A, Mookhoek A, D'Haens G, Stoker J, Gecse KB. PMID: 40516640 [PubMed - as supplied by publisher]
	Unmet health-related needs in patients with Crohn's disease in Belgium: a mixed-methods study. Arch Public Health Schönborn C, Levy M, De Jaeger M, Van Goethem R, Leonard U, Claerman R, De Pauw R, Kohn L, Cleemput I, de Noordhout CM. PMID: 40514703 [PubMed]
	A Randomized Controlled Trial Of Antibiotics Targeting Adherent And Invasive Escherichia Coli (Aiec) Vs Placebo In Crohn's Disease: The Teorem Trial. J Crohns Colitis Carbonnel F, Barnich N, Lepage P, Hébuterne X, Michiels C, Gilletta C, Wils P, Laharie D, Altwegg R, Allez M, Bouhnik Y, Meyer A, Breton C, Agostini H, Molinari D, Balfour Sartor R, Mary JY, Colombel JF, Chevarin C, Faure F, Walter-Petrich A, Chevret S, Buisson A. PMID: 40512677 [PubMed - as supplied by publisher]
	Effectiveness and safety of intravenous iron in ulcerative colitis: A real-world study of impact of disease activity and iron preparations. Indian J Gastroenterol Kochai AR, Mangipudi UK, Bhatia P, Sekar A, Mandavdhare HS, Jearth V, Sharma V. PMID: 40512340 [PubMed - as supplied by publisher]
	Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey. J Crohns Colitis Fiorino G, Walsh A, Adamina M, Barreiro-Acosta M, Ali MP, Bortlik M, Burisch J, Dignass A, Drobne D, Faiz O, Ferrante M, Fierens L, Godny L, Gojdicova A, Iacucci M, J, Karmiris K, Kirchgesner J, Restellini S, Rosini F, Shouval D, Van Deen W, Yanai H, Zagórowicz E, Fidalgo C, European Crohn. PMID: 40512137 [PubMed - as supplied by publisher]
	Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial. Inflamm Bowel Dis Yogev D, Weintraub Y, Ledder O, Matar M, Krauthammer A, Shavit-Brunschwig Z, Rotstein A, Godfrey ME, Assa A, Shamir R, Turner D, Salomon N, Orlanski-Meyer E, Shouval DS. PMID: 40512056 [PubMed - as supplied by publisher]
	A Guide to the Patient-Centric Use of Vedolizumab for Crohn's Disease. Inflamm Bowel Dis Rubin DT, Hart AL. PMID: 40512051 [PubMed - as supplied by publisher]
	Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitis. iScience Dang Y, Xu X, Ma J, Zhou M, Xu C, Huang X, Xu F, Wang Z, Shi H, Zhang S. PMID: 40510115 [PubMed]
	TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential. Int J Mol Sci Tettoni E, Gabbiadini R, Dal Buono A, Privitera G, Vadalà V, Migliorisi G, Bertoli P, Quadarella A, Bezzio C, Armuzzi A. PMID: 40507829 [PubMed - indexed for MEDLINE]
	Integrating Proteomics into Personalized Medicine for Inflammatory Bowel Disease-Reality or Challenge? Int J Mol Sci Minea H, Singeap AM, Minea M, Juncu S, Chiriac SA, Sfarti CV, Stanciu C, Trifan A. PMID: 40507799 [PubMed - indexed for MEDLINE]
	Inflammatory Bowel Disease (IBD)-Associated Colorectal Cancer (CRC): Is cGAS-STING Pathway Targeting the Key to Chemoprevention? Int J Mol Sci Papadakos SP, Georgiadou C, Argyrou A, Michailidou E, Thanos C, Vogli S, Siakavellas SI, Manolakopoulos S, Theocharis S. PMID: 40507791 [PubMed - indexed for MEDLINE]
	Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Adult Patients with Crohn's Disease: Protocol for a Prospective, Interventional, Controlled, Randomized Clinical Trial. J Clin Med Cano-Mármol RP, Fernández-Ruiz VE, Martínez-Pascual C, Ros-Madrid I, Martín-Pozuelo G, Oliva-Bolarín A, Martínez-Sánchez MA, Egea-Valenzuela J, Núñez-Sánchez MÁ, Ramos-Molina B, Ruiz-Alcaraz AJ, Ferrer-Gómez M. PMID: 40507757 [PubMed]

Artikel 1 - 20 / 53973

Seite 1 von 2699



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung